Congress should not extend another dollar in subsidies without insisting on transparency, rooting out abuse, and ensuring that taxpayer dollars actually benefit patients — not insurers’ bottom lines.
Executives from the nation’s largest health insurers are set to testify before Congress soon in a hearing on healthcare affordability.
It’s about time.
From Medicare Advantage to Obamacare exchanges to prescription drug benefits, insurers have been extracting ever-greater amounts of public funds while passing costs and risk on to patients and taxpayers.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
No Accountability as Insurers Profit From Public Programs
Sally C. Pipes
Congress should not extend another dollar in subsidies without insisting on transparency, rooting out abuse, and ensuring that taxpayer dollars actually benefit patients — not insurers’ bottom lines.
Executives from the nation’s largest health insurers are set to testify before Congress soon in a hearing on healthcare affordability.
It’s about time.
From Medicare Advantage to Obamacare exchanges to prescription drug benefits, insurers have been extracting ever-greater amounts of public funds while passing costs and risk on to patients and taxpayers.
Read the op-ed here.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.